Niacin (nicotinic acid) and heart

What 3 graded rows on niacin (nicotinic acid) agree on for heart, and where they differ. Counted side by side, never averaged.

What the rows agree on

Each block and row is one graded row from the Niacin (nicotinic acid) page, with its PubMed record.

Your question

Supplement
Niacin (nicotinic acid) Choose another

Niacin (nicotinic acid) and heart

3 rows · 68,282 people

They agree: all 3 rows found no difference.

Improved
Each block is one evidence row, sized by how many people it enrolled, with its grade inside.
  • No effect× 3
Rows
3
Trials
25
People
68,282
Pooled reviews may count some twice

What the rows share

From the rows

Every row is graded No effect, our grade for adequately powered trials that found no effect.

The rows run from 3,414 to 39,195 people, published from 2011 to 2017: 1 pooled review and 2 single studies.

The rows

3 no difference
  1. No effectMortality, heart attack and stroke · No difference

    Meta-analysis, 23 studies · n 39,195 · 2017 · Adults with or without cardiovascular disease in 23 RCTs (median 48% with prior MI)

    Median 2 g/day · Median 11.5 months

    No reduction in overall mortality (RR 1.05), cardiovascular mortality (RR 1.02), heart attacks (RR 0.93) or strokes (RR 0.95).

    Row on the Niacin (nicotinic acid) page · PubMed 28616955 (opens PubMed)

  2. No effectMajor vascular events on top of statins · No difference

    RCT · n 25,673 · 2014 · Adults with vascular disease on statin therapy

    2 g/day niacin + 40 mg laropiprant · Median 3.9 years

    Major vascular events 13.2% vs 13.7% (rate ratio 0.96); excess serious diabetes complications (+3.7 points), new diabetes (+1.3), GI, muscle, skin, infection and bleeding events.

    Row on the Niacin (nicotinic acid) page · PubMed 25014686 (opens PubMed)

  3. No effectCardiovascular events with intensive statin therapy · No difference

    RCT · n 3,414 · 2011 · Adults with atherosclerotic disease and low HDL on simvastatin

    1,500–2,000 mg/day · Mean 3 years (stopped early)

    HDL rose from 35 to 42 mg/dL and triglycerides fell, but the primary endpoint occurred in 16.4% vs 16.2% (HR 1.02).

    Row on the Niacin (nicotinic acid) page · PubMed 22085343 (opens PubMed)

Educational only. Not medical advice. Some links earn us a commission: kymatahealth.com/affiliate-disclosure.